You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
McKinsey
McKesson
Colorcon
Merck

Last Updated: May 28, 2020

DrugPatentWatch Database Preview

FLUOTREX Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Fluotrex, and what generic alternatives are available?

Fluotrex is a drug marketed by Savage Labs and is included in four NDAs.

The generic ingredient in FLUOTREX is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.

Summary for FLUOTREX
Drug patent expirations by year for FLUOTREX
Synonyms for FLUOTREX
(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-16-one
(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
(2S,6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10,10-tetramethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[
(2S,6aS,6bR,7S,8aS,8bS,11aR,12aS,12bS)-2,6b-difluoro-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10,10-tetramethyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-Difluoro-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aS,4bR,5S,6aS,6bS,9aR,10aS,10bS,12S)-4b,12-difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(6alpha,11beta,16alpha)-6,9-Difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione
010F525
0CD5FD6S2M
2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one
4b,12-Difluoro-6b-glycoloyl-5-hydroxy-4a,6a,8,8-tetramethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
6-alpha,9-alpha-Difluoro-16-alpha-hydroxyprednisolone 16,17-acetonide
6.alpha.-Fluorotriamcinolone acetonide
6.alpha., 9.alpha.-Difluoro-16.alpha.-hydroxyprednisolone 16,17-acetonide
6.alpha.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone
6.alpha.,17-acetonide
6.Alpha.,9-Difluoro
6|A,9|A-Difluoro-11|A,16|A,17|A,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 16,17-acetonide
67-73-2
6alpha-Fluorotriamcinolone acetonide
6alpha,9-Difluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, cyclic 16,17-acetal with acetone
6alpha,9alpha-Difluoro-11beta,16alpha,17alpha,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 16,17-Acetonide
6alpha,9alpha-difluoro-11beta,21-dihydroxy-16alpha-17alpha-isopropylidenedioxypregna-1,4-diene-3,20-dione;
6alpha,9alpha-Difluoro-16alpha-hydroxyprednisolone 16,17-acetonide
AB00383017_11
AB00383017-10
AB1010906
AC-429
Acetonida de fluocinolona
Acetonida de fluocinolona [INN-Spanish]
Acetonide de fluocinolone
Acetonide de fluocinolone [INN-French]
acetonido de fluocinolona
ACN-043362
AKOS015963144
ARONIS24561
AS-13690
BRD-K94353609-001-21-6
C-22503
C24H30F2O6
Capex
CAS-67-73-2
CC-28473
CCG-221165
CCRIS 3250
CHEBI:31623
CHEMBL989
component of Neo-Synalar
Coriphate
Cortiplastol
CS-2519
D01825
DB00591
Derma-smoothe/fs
Dermalar
Dermatin
Dermatin (steroid)
difluoro-hydroxy-(2-hydroxyacetyl)-tetramethyl-[?]one
DSSTox_CID_20674
DSSTox_GSID_40674
DSSTox_RID_79533
DTXSID0040674
EBD4852
EINECS 200-668-5
F0657
FEBLZLNTKCEFIT-VSXGLTOVSA-N
Flucinar
flucinolone
Flucort
Flucort-N
Fluocet
Fluocet (TN)
Fluocinolonacetonidum
Fluocinolone (Acetonide)
Fluocinolone 16,17-acetonide
FLUOCINOLONE ACETONIDE
Fluocinolone acetonide (Flucort-N)
Fluocinolone acetonide (JP17/USP/INN)
Fluocinolone acetonide [DCIT]
Fluocinolone acetonide [USAN:INN:JAN]
Fluocinolone acetonide [USAN:USP:INN:JAN]
Fluocinolone acetonide for peak identification, European Pharmacopoeia (EP) Reference Standard
Fluocinolone acetonide for system suitability, European Pharmacopoeia (EP) Reference Standard
Fluocinolone acetonide intravitreal implant
Fluocinolone acetonide, analytical standard
Fluocinolone acetonide, European Pharmacopoeia (EP) Reference Standard
Fluocinolone Acetonide, Pharmaceutical Secondary Standard; Certified Reference Material
Fluocinolone acetonide, United States Pharmacopeia (USP) Reference Standard
Fluocinolone acetonide(Flucort-N)
Fluocinolone-acetonide(Flucort-N)
Fluocinoloneacetonide
Fluocinoloni acetonidum
Fluocinoloni acetonidum [INN-Latin]
Fluonid
Fluortriamcinolone Acetonide
Fluovitif
Flupollon
Fluzon [Steroid]
Fs Shampoo
GTPL7077
HMS2090I14
HMS2230D13
HMS3259G12
HMS3715J11
HSDB 3083
HY-B0415
Iluvien
J10113
Jellin
Localyn
Localyn Syntex
LS-118443
MFCD00010525
MLS000028545
MLS001076276
NC00562
NCGC00021301-04
NCGC00021301-06
NCGC00255654-01
NCI60_042042
NSC 92339
NSC-92339
NSC92339
Omniderm
Opera_ID_1295
Percutina
Pregna-1,20-dione, 6,9-difluoro-11,12-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6.alpha.,11.beta.,16.alpha.)-
Pregna-1,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)-, (6.alpha.,11.beta.,16.alpha.)-
Pregna-1,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6.alpha.,11.beta.,16.alpha.)-
Pregna-1,20-dione, 6.alpha.,9-difluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone
Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,12-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6-alpha,11-beta,16-alpha)-
Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6alpha,11beta,16alpha)-
Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone
Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,16alpha,17,21-tetrahydroxy-, cyclic 16,17-acetal with acetone (8CI)
Prodermin
Q924467
Radiocin
Retisert
Retisert (TN)
RS 1401AT
RS-1401 AT
s2470
SCHEMBL4795
Sinalar
SMR000058329
SR-01000000109
SR-01000000109-2
Synalar
Synalar (TN)
Synalar-HP
Synamol
Synandone
Synandrone
Synemol
Synotic
Synsac
Tefunote
Tox21_110869
Tox21_110869_1
Tox21_302364
UNII-0CD5FD6S2M
W-104704
WLN: T F5 E5 B666 GO IO RV AHTTTT&J A BF CQ E FVIQ H H OF -A&BHO -B&ACEF
ZINC3977981

US Patents and Regulatory Information for FLUOTREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Savage Labs FLUOTREX fluocinolone acetonide CREAM;TOPICAL 088174-001 May 6, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Savage Labs FLUOTREX fluocinolone acetonide SOLUTION;TOPICAL 088171-001 Mar 9, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Savage Labs FLUOTREX fluocinolone acetonide CREAM;TOPICAL 088173-001 Mar 9, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Savage Labs FLUOTREX fluocinolone acetonide OINTMENT;TOPICAL 088172-001 Mar 9, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Johnson and Johnson
McKinsey
McKesson
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.